Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
The optimal duration of immunotherapy treatment for cancer patients is unknown. As the survival data from early immunotherapy trials mature we are beginning to appreciate how durable responses can be post-discontinuation. The purpose of this brief communication is to comment on treatment duration of immunotherapy in patients with melanoma and non-small cell lung cancer and to provide practice guidance in support of discontinuation.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/imj.14919 | DOI Listing |
Publication Analysis
Top Keywords
duration immunotherapy
12
immunotherapy continue
4
continue infinitum?
4
infinitum? optimal
4
optimal duration
4
immunotherapy treatment
4
treatment cancer
4
cancer patients
4
patients unknown
4
unknown survival
4